The State of Metabolic Health in America, 2026 Baseline Edition · James M. Knox · DOI: 10.5281/zenodo.22772957 · Last reviewed: October 2026

ACCESS model maximum payment reduction for underperformance

Metric MA-10 · Series MA: Medicare

ACCESS model maximum payment reduction for underperformance was 50% in 2026, according to CMS Innovation Center.

This figure is reported as Metric MA-10 in The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report (James M. Knox, DOI: 10.5281/zenodo.22772957).

Definition

This metric measures access model maximum payment reduction for underperformance among access model participants. The unit of measurement is percent of Outcome-Aligned Payment. The geographic scope is United States.

Reduction applies only to the extent performance falls short of the 50% beneficiary target threshold.

Current Value

ValueData YearPopulationGeography
50%2026ACCESS model participantsUnited States

Source

CMS Innovation Center.

Methodological Notes

This figure is drawn from CMS Innovation Center. Where a second source reports a different figure for the same condition, both values and the reason for the discrepancy are documented in the report rather than reconciled.

See Methodology and Sources for the full source selection criteria and conflict resolution approach.

Cite This Metric

ACCESS model maximum payment reduction for underperformance, Metric MA-10. In Knox, J. M. (2026). The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report. Zenodo. https://doi.org/10.5281/zenodo.22772957

Last reviewed: October 2026

How to cite this page

ACCESS model maximum payment reduction for underperformance, Metric MA-10. In Knox, J. M. (2026). The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report. Zenodo. https://doi.org/10.5281/zenodo.22772957

© 2026 James M. Knox. Figures may be reproduced with attribution: Knox, J. M. (2026). The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report. Zenodo. https://doi.org/10.5281/zenodo.22772957 ISSN 3144-8178 (Online)